NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 184 filers reported holding NEKTAR THERAPEUTICS in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $9,001,000 | -3.8% | 733,599 | +34.6% | 0.01% | -16.7% |
Q3 2016 | $9,361,000 | +14.7% | 544,904 | -5.0% | 0.01% | +20.0% |
Q2 2016 | $8,160,000 | -9.2% | 573,469 | -12.2% | 0.01% | -16.7% |
Q1 2016 | $8,983,000 | -16.3% | 653,281 | +2.6% | 0.01% | -14.3% |
Q4 2015 | $10,731,000 | +55.8% | 636,866 | +1.3% | 0.01% | +55.6% |
Q3 2015 | $6,888,000 | -4.8% | 628,436 | +8.7% | 0.01% | 0.0% |
Q2 2015 | $7,235,000 | +75.9% | 578,311 | +54.7% | 0.01% | +80.0% |
Q1 2015 | $4,113,000 | -28.7% | 373,919 | +0.5% | 0.01% | -37.5% |
Q4 2014 | $5,769,000 | +28.8% | 372,193 | +0.3% | 0.01% | +33.3% |
Q3 2014 | $4,479,000 | -5.3% | 371,110 | +0.6% | 0.01% | 0.0% |
Q2 2014 | $4,728,000 | +5.4% | 368,788 | -0.3% | 0.01% | -14.3% |
Q1 2014 | $4,485,000 | +16.0% | 370,060 | +8.7% | 0.01% | +16.7% |
Q4 2013 | $3,865,000 | +6.2% | 340,493 | -2.3% | 0.01% | 0.0% |
Q3 2013 | $3,641,000 | -5.9% | 348,631 | +4.0% | 0.01% | -14.3% |
Q2 2013 | $3,871,000 | – | 335,190 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |